186 related articles for article (PubMed ID: 24266878)
21. Topical glycopyrrolate should not be overlooked in treatment of focal hyperhidrosis.
Kavanagh GM; Burns C; Aldridge RD
Br J Dermatol; 2006 Aug; 155(2):487. PubMed ID: 16882200
[No Abstract] [Full Text] [Related]
22. Iontophoresis with glycopyrrolate for the treatment of palmoplantar hyperhidrosis.
Dolianitis C; Scarff CE; Kelly J; Sinclair R
Australas J Dermatol; 2004 Nov; 45(4):208-12. PubMed ID: 15527429
[TBL] [Abstract][Full Text] [Related]
23. Urinary retention caused by topical glycopyrrolate for hyperhidrosis.
Madan V; Beck MH
Br J Dermatol; 2006 Sep; 155(3):634-5. PubMed ID: 16911300
[No Abstract] [Full Text] [Related]
24. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
Pariser DM; Lain EL; Mamelok RD; Drew J; Mould DR
Clin Pharmacokinet; 2021 May; 60(5):665-676. PubMed ID: 33433785
[TBL] [Abstract][Full Text] [Related]
25. Treatment of compensatory gustatory hyperhidrosis with topical glycopyrrolate.
Kim WO; Kil HK; Yoon DM; Cho MJ
Yonsei Med J; 2003 Aug; 44(4):579-82. PubMed ID: 12950111
[TBL] [Abstract][Full Text] [Related]
26. Survival study of treatment adherence by patients given oral glycopyrrolate for hyperhidrosis following treatment failure with oral oxybutynin.
Del Boz J; García-Souto F; Rivas-Ruiz F; Polo-Padillo J
Dermatol Ther; 2020 Nov; 33(6):e14210. PubMed ID: 32827198
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of oral anticholinergics for sympathetic overactivity in a thoracic surgery clinic.
Hynes CF; Seevaratnam S; Gesuwan K; Margolis M; Marshall MB
J Thorac Cardiovasc Surg; 2016 Aug; 152(2):565-8. PubMed ID: 27160942
[TBL] [Abstract][Full Text] [Related]
28. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
Hebert AA; Glaser DA; Green L; Werschler WP; Forsha DW; Drew J; Gopalan R; Pariser DM
Pediatr Dermatol; 2019 Jan; 36(1):89-99. PubMed ID: 30451318
[TBL] [Abstract][Full Text] [Related]
29. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.
Arbouw ME; Movig KL; Koopmann M; Poels PJ; Guchelaar HJ; Egberts TC; Neef C; van Vugt JP
Neurology; 2010 Apr; 74(15):1203-7. PubMed ID: 20385892
[TBL] [Abstract][Full Text] [Related]
30. [A medical alternative for the treatment of localized hyperhidrosis].
Cladellas Gutiérrez E; Callejas Pérez MA; Grimalt Santacana R
Arch Bronconeumol; 2008 Dec; 44(12):692-3. PubMed ID: 19091240
[No Abstract] [Full Text] [Related]
31. A case of isolated axillary hyperhidrosis successfully treated topically with 1% glycopyrronium cream.
Sega-Hall GM; Smith P; Haworth AE
Clin Exp Dermatol; 2006 Nov; 31(6):825. PubMed ID: 17040271
[No Abstract] [Full Text] [Related]
32. [Use of oral oxybutynin at 7.5 mg per day in primary hyperhidrosis].
Try C; Messikh R; Elkhyat A; Aubin F; Humbert RP
Rev Med Liege; 2012 Oct; 67(10):520-6. PubMed ID: 23167161
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double-blinded, placebo-controlled, split-face study.
Hyun MY; Son IP; Lee Y; Choi HG; Park KY; Li K; Kim BJ; Seo SJ; Kim MN; Hong CK
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):278-282. PubMed ID: 24909188
[TBL] [Abstract][Full Text] [Related]
34. Glycopyrrolate for antidepressant-associated excessive sweating.
Mago R
J Clin Psychopharmacol; 2013 Apr; 33(2):279-80. PubMed ID: 23422382
[No Abstract] [Full Text] [Related]
35. [Formulation of topical glycopyrrolate for hyperhidrosis].
Albornoz López R; Arias Rico R; Torres Degayón V; Gago Sánchez A
Farm Hosp; 2008; 32(6):362-3. PubMed ID: 19232224
[No Abstract] [Full Text] [Related]
36. Oral glycopyrrolate for the treatment of Hailey-Hailey disease.
Kaniszewska M; Rovner R; Arshanapalli A; Tung R
JAMA Dermatol; 2015 Mar; 151(3):328-9. PubMed ID: 25651401
[No Abstract] [Full Text] [Related]
37. The use of topical glycopyrrolate in the treatment of hyperhidrosis.
Seukeran DC; Highet AS
Clin Exp Dermatol; 1998 Sep; 23(5):204-5. PubMed ID: 10233600
[TBL] [Abstract][Full Text] [Related]
38. Adjusting oral glycopyrrolate medication for hyperhidrosis to reflect seasonal temperature variations.
Garcia-Souto F; Del Boz J; Polo-Padillo J
Dermatol Ther; 2020 Nov; 33(6):e14249. PubMed ID: 32860330
[TBL] [Abstract][Full Text] [Related]
39. Oral oxybutynin for the treatment of hyperhidrosis: outcomes after one-year follow-up.
Millán-Cayetano JF; Del Boz J; Rivas-Ruiz F; Blázquez-Sánchez N; Hernández Ibáñez C; de Troya-Martín M
Australas J Dermatol; 2017 May; 58(2):e31-e35. PubMed ID: 27029500
[TBL] [Abstract][Full Text] [Related]
40. Oxybutynin therapy for generalized hyperhidrosis.
Tupker RA; Harmsze AM; Deneer VH
Arch Dermatol; 2006 Aug; 142(8):1065-6. PubMed ID: 16924061
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
